Cargando…
Atorvastatin potentiates the chemosensitivity of human liver cancer cells to cisplatin via downregulating YAP1
Atorvastatin is a competitive inhibitor of β-hydroxy β-methylglutaryl-CoA reductase, which is involved in anticancer effects in numerous types of cancer, including in human liver cancer. However, its functions and underlying mechanisms of chemosensitivity in liver cancer remain to be elucidated. The...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723154/ https://www.ncbi.nlm.nih.gov/pubmed/33363619 http://dx.doi.org/10.3892/ol.2020.12343 |